RNA expression of the WT1 gene in Wilms' tumors in relation to histology

Hiroshi Miwa, Gail E. Tomlinson, Charles F. Timmons, Vicki Huff, Susan L. Cohn, Louise C. Strong, Grady F. Saunders

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: On the basis of accumulating data, the recently isolated WT1 gene is a Wilms' tumor gene and a putative tumor suppressor gene. These findings include expression in developing fetal kidney, intragenic deletions in tumors, and germline mutations in predisposed individuals. Wilms' tumors, which exhibit a broad range of differentiation, are composed of three cell types: blastema, epithelium, and stroma. Purpose: The purpose of this study was to investigate the relationship between WT1 gene expression and histologic composition in Wilms' tumors in an effort to elucidate how the WT1 gene functions in proliferation of these histologic components. Methods: We used Northern blot hybridization to study WT1 gene expression by messenger RNA (mRNA) accumulation in 20 tumors of varying histology and in adjacent uninvolved kidney tissue. In two patients, tumors were also compared before and after therapy. Results: Tumors that were predominantly blastemal expressed high amounts of WT1 mRNA, whereas predominantly stromal tumors expressed either low or undetectable amounts. Blastemal tumors that were predominantly poorly differentiated expressed WT1 mRNA at higher levels than those that were more well differentiated. Although we expected that a putative tumor suppressor gene like WT1 would generally be expressed at lower levels in tumor than in normal kidney, this was true only in predominantly stromal cells. One of the two patients studied before and after therapy had a dramatic response to therapy accompanied by a decline in WT1 gene expression and disappearance of blastemal and epithelial elements. Conclusions: A correlation was observed between WT1 gene expression and histology of the tumors. Level of expression was inversely related to the degree of differentiation in blastemal tumors and in the patient with a dramatic response to therapy. These results, in conjunction with the observation that WT1 mRNA is abundant in normal fetal kidney, suggest that WT1 gene expression is related to kidney development, especially in differentiation of blastemal components. Implications: Further studies to search for alterations of the WT1 gene in tumors and to identify regulatory factors in gene expression will increase understanding of the role of this gene in normal development and tumorigenesis.

Original languageEnglish (US)
Pages (from-to)181-187
Number of pages7
JournalJournal of the National Cancer Institute
Volume84
Issue number3
StatePublished - Feb 5 1992

Fingerprint

Wilms' Tumor Genes
Histology
RNA
Tumors
Tumor
Genes
Gene
Neoplasms
Gene Expression
Gene expression
Kidney
Messenger RNA
Therapy
Wilms Tumor
Tumor Suppressor Genes
Germ-Line Mutation
Therapeutics
Stromal Cells
Northern Blotting
Carcinogenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging

Cite this

Miwa, H., Tomlinson, G. E., Timmons, C. F., Huff, V., Cohn, S. L., Strong, L. C., & Saunders, G. F. (1992). RNA expression of the WT1 gene in Wilms' tumors in relation to histology. Journal of the National Cancer Institute, 84(3), 181-187.

RNA expression of the WT1 gene in Wilms' tumors in relation to histology. / Miwa, Hiroshi; Tomlinson, Gail E.; Timmons, Charles F.; Huff, Vicki; Cohn, Susan L.; Strong, Louise C.; Saunders, Grady F.

In: Journal of the National Cancer Institute, Vol. 84, No. 3, 05.02.1992, p. 181-187.

Research output: Contribution to journalArticle

Miwa, H, Tomlinson, GE, Timmons, CF, Huff, V, Cohn, SL, Strong, LC & Saunders, GF 1992, 'RNA expression of the WT1 gene in Wilms' tumors in relation to histology', Journal of the National Cancer Institute, vol. 84, no. 3, pp. 181-187.
Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC et al. RNA expression of the WT1 gene in Wilms' tumors in relation to histology. Journal of the National Cancer Institute. 1992 Feb 5;84(3):181-187.
Miwa, Hiroshi ; Tomlinson, Gail E. ; Timmons, Charles F. ; Huff, Vicki ; Cohn, Susan L. ; Strong, Louise C. ; Saunders, Grady F. / RNA expression of the WT1 gene in Wilms' tumors in relation to histology. In: Journal of the National Cancer Institute. 1992 ; Vol. 84, No. 3. pp. 181-187.
@article{10c35fbc07e1449db2cbb88dd0685881,
title = "RNA expression of the WT1 gene in Wilms' tumors in relation to histology",
abstract = "Background: On the basis of accumulating data, the recently isolated WT1 gene is a Wilms' tumor gene and a putative tumor suppressor gene. These findings include expression in developing fetal kidney, intragenic deletions in tumors, and germline mutations in predisposed individuals. Wilms' tumors, which exhibit a broad range of differentiation, are composed of three cell types: blastema, epithelium, and stroma. Purpose: The purpose of this study was to investigate the relationship between WT1 gene expression and histologic composition in Wilms' tumors in an effort to elucidate how the WT1 gene functions in proliferation of these histologic components. Methods: We used Northern blot hybridization to study WT1 gene expression by messenger RNA (mRNA) accumulation in 20 tumors of varying histology and in adjacent uninvolved kidney tissue. In two patients, tumors were also compared before and after therapy. Results: Tumors that were predominantly blastemal expressed high amounts of WT1 mRNA, whereas predominantly stromal tumors expressed either low or undetectable amounts. Blastemal tumors that were predominantly poorly differentiated expressed WT1 mRNA at higher levels than those that were more well differentiated. Although we expected that a putative tumor suppressor gene like WT1 would generally be expressed at lower levels in tumor than in normal kidney, this was true only in predominantly stromal cells. One of the two patients studied before and after therapy had a dramatic response to therapy accompanied by a decline in WT1 gene expression and disappearance of blastemal and epithelial elements. Conclusions: A correlation was observed between WT1 gene expression and histology of the tumors. Level of expression was inversely related to the degree of differentiation in blastemal tumors and in the patient with a dramatic response to therapy. These results, in conjunction with the observation that WT1 mRNA is abundant in normal fetal kidney, suggest that WT1 gene expression is related to kidney development, especially in differentiation of blastemal components. Implications: Further studies to search for alterations of the WT1 gene in tumors and to identify regulatory factors in gene expression will increase understanding of the role of this gene in normal development and tumorigenesis.",
author = "Hiroshi Miwa and Tomlinson, {Gail E.} and Timmons, {Charles F.} and Vicki Huff and Cohn, {Susan L.} and Strong, {Louise C.} and Saunders, {Grady F.}",
year = "1992",
month = "2",
day = "5",
language = "English (US)",
volume = "84",
pages = "181--187",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - RNA expression of the WT1 gene in Wilms' tumors in relation to histology

AU - Miwa, Hiroshi

AU - Tomlinson, Gail E.

AU - Timmons, Charles F.

AU - Huff, Vicki

AU - Cohn, Susan L.

AU - Strong, Louise C.

AU - Saunders, Grady F.

PY - 1992/2/5

Y1 - 1992/2/5

N2 - Background: On the basis of accumulating data, the recently isolated WT1 gene is a Wilms' tumor gene and a putative tumor suppressor gene. These findings include expression in developing fetal kidney, intragenic deletions in tumors, and germline mutations in predisposed individuals. Wilms' tumors, which exhibit a broad range of differentiation, are composed of three cell types: blastema, epithelium, and stroma. Purpose: The purpose of this study was to investigate the relationship between WT1 gene expression and histologic composition in Wilms' tumors in an effort to elucidate how the WT1 gene functions in proliferation of these histologic components. Methods: We used Northern blot hybridization to study WT1 gene expression by messenger RNA (mRNA) accumulation in 20 tumors of varying histology and in adjacent uninvolved kidney tissue. In two patients, tumors were also compared before and after therapy. Results: Tumors that were predominantly blastemal expressed high amounts of WT1 mRNA, whereas predominantly stromal tumors expressed either low or undetectable amounts. Blastemal tumors that were predominantly poorly differentiated expressed WT1 mRNA at higher levels than those that were more well differentiated. Although we expected that a putative tumor suppressor gene like WT1 would generally be expressed at lower levels in tumor than in normal kidney, this was true only in predominantly stromal cells. One of the two patients studied before and after therapy had a dramatic response to therapy accompanied by a decline in WT1 gene expression and disappearance of blastemal and epithelial elements. Conclusions: A correlation was observed between WT1 gene expression and histology of the tumors. Level of expression was inversely related to the degree of differentiation in blastemal tumors and in the patient with a dramatic response to therapy. These results, in conjunction with the observation that WT1 mRNA is abundant in normal fetal kidney, suggest that WT1 gene expression is related to kidney development, especially in differentiation of blastemal components. Implications: Further studies to search for alterations of the WT1 gene in tumors and to identify regulatory factors in gene expression will increase understanding of the role of this gene in normal development and tumorigenesis.

AB - Background: On the basis of accumulating data, the recently isolated WT1 gene is a Wilms' tumor gene and a putative tumor suppressor gene. These findings include expression in developing fetal kidney, intragenic deletions in tumors, and germline mutations in predisposed individuals. Wilms' tumors, which exhibit a broad range of differentiation, are composed of three cell types: blastema, epithelium, and stroma. Purpose: The purpose of this study was to investigate the relationship between WT1 gene expression and histologic composition in Wilms' tumors in an effort to elucidate how the WT1 gene functions in proliferation of these histologic components. Methods: We used Northern blot hybridization to study WT1 gene expression by messenger RNA (mRNA) accumulation in 20 tumors of varying histology and in adjacent uninvolved kidney tissue. In two patients, tumors were also compared before and after therapy. Results: Tumors that were predominantly blastemal expressed high amounts of WT1 mRNA, whereas predominantly stromal tumors expressed either low or undetectable amounts. Blastemal tumors that were predominantly poorly differentiated expressed WT1 mRNA at higher levels than those that were more well differentiated. Although we expected that a putative tumor suppressor gene like WT1 would generally be expressed at lower levels in tumor than in normal kidney, this was true only in predominantly stromal cells. One of the two patients studied before and after therapy had a dramatic response to therapy accompanied by a decline in WT1 gene expression and disappearance of blastemal and epithelial elements. Conclusions: A correlation was observed between WT1 gene expression and histology of the tumors. Level of expression was inversely related to the degree of differentiation in blastemal tumors and in the patient with a dramatic response to therapy. These results, in conjunction with the observation that WT1 mRNA is abundant in normal fetal kidney, suggest that WT1 gene expression is related to kidney development, especially in differentiation of blastemal components. Implications: Further studies to search for alterations of the WT1 gene in tumors and to identify regulatory factors in gene expression will increase understanding of the role of this gene in normal development and tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=0026585964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026585964&partnerID=8YFLogxK

M3 - Article

C2 - 1311774

AN - SCOPUS:0026585964

VL - 84

SP - 181

EP - 187

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -